Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Aug-24 8:00 AM View:  | Knie Robb CEO and President Director | Hoth Therapeutics, Inc. (HOTH) | 16-Aug-24 | Private Purchase | 25,000 | $0.67 | $16,750.00 | 75% 33.13K to 58.13K | |
| 13-Dec-22 4:40 PM View: | Pavell Jeff Director | Hoth Therapeutics, Inc. (HOTH) | 13-Dec-22 | Grant | 5,075 | -- | -- | 100% 0 to 5.08K | |
| 20-Sep-22 8:00 AM View: | Knie Robb CEO and President Director | Hoth Therapeutics, Inc. (HOTH) | 19-Sep-22 | Private Purchase | 10,000 | $0.39 | $3,900.00 | 1% 818.26K to 828.26K | |
| 19-Sep-22 11:05 AM View: | Knie Robb CEO and President Director | Hoth Therapeutics, Inc. (HOTH) | 16-Sep-22 | Private Purchase | 10,000 | $0.40 | $4,000.00 | 1% 808.26K to 818.26K | |
| 29-May-20 4:23 PM View: | Hayes Anthony | Hoth Therapeutics, Inc. (HOTH) | 26-May-20 | Sale | 400,000 | $1.25 | $500,000.00 | (26%) 1.53M to 1.13M | |
| 16-Feb-21 10:00 PM View: | Spherix Inc 10% Owner | Hoth Therapeutics, Inc. (HOTH) | 26-May-20 | Sale | 400,000 | $1.25 | $500,000.00 | (26%) 1.53M to 1.13M | |
| 11-Feb-21 10:00 PM View: | Knie Robb CEO and President Director | Hoth Therapeutics, Inc. (HOTH) | 18-May-20 | Acquisition (other) | 4 | -- | -- | < 1% 808.25K to 808.26K | |
| 16-Apr-20 4:15 PM View: | Springer Graig Director | Hoth Therapeutics, Inc. (HOTH) | 15-Apr-20 | Grant | 3,333 | -- | -- | 100% 0 to 3.33K | |
| 17-Apr-20 4:20 PM View: | Linsley Wayne Director | Hoth Therapeutics, Inc. (HOTH) | 15-Apr-20 | Grant | 3,333 | -- | -- | 100% 0 to 3.33K | |
| 14-Feb-20 10:00 PM View: | Hayes Anthony Director | Hoth Therapeutics, Inc. (HOTH) | 08-Nov-19 | Disposition (other) Duplicate | 9,226 | -- | -- | (< 1%) 1.72M to 1.71M | |
| 28-Feb-20 10:00 PM View: | Spherix Inc 10% Owner | Hoth Therapeutics, Inc. (HOTH) | 08-Nov-19 | Disposition (other) | 9,226 | -- | -- | (< 1%) 3.35M to 3.34M | |
| 14-Feb-20 10:00 PM View: | Hayes Anthony Director | Hoth Therapeutics, Inc. (HOTH) | 28-Oct-19 | Acquisition (other) | 301 | -- | -- | < 1% 1.8M to 1.81M | |
| 28-Feb-20 10:00 PM View: | Spherix Inc 10% Owner | Hoth Therapeutics, Inc. (HOTH) | 28-Oct-19 | Disposition (other) | 90,258 | -- | -- | (3%) 3.44M to 3.35M | |
| 14-Feb-20 10:00 PM View: | Hayes Anthony Director | Hoth Therapeutics, Inc. (HOTH) | 28-Oct-19 | Disposition (other) Duplicate | 90,258 | -- | -- | (5%) 1.81M to 1.72M | |
| 14-Feb-20 10:00 PM View: | Knie Robb CEO and President Director | Hoth Therapeutics, Inc. (HOTH) | 28-Oct-19 | Acquisition (other) | 85 | -- | -- | < 1% 808.17K to 808.25K | |
| 28-Feb-20 10:00 PM View: | Spherix Inc 10% Owner | Hoth Therapeutics, Inc. (HOTH) | 28-Feb-19 | Purchase | 35,714 | $199,998.00 | $7,142,730,240.00 | 1% 3.4M to 3.44M | |
| 04-Mar-19 4:30 PM View: | Eitner Matthew D. 10% Owner | Hoth Therapeutics, Inc. (HOTH) | 20-Feb-19 | Conversion | 15,000 | -- | -- | 2% 750.0K to 765.0K | |
| 04-Mar-19 4:32 PM View: | Poor Kevin Jess 10% Owner | Hoth Therapeutics, Inc. (HOTH) | 20-Feb-19 | Conversion | 750,000 | -- | -- | 100% 0 to 750.0K | |
| 28-Feb-20 10:00 PM View: | Spherix Inc 10% Owner | Hoth Therapeutics, Inc. (HOTH) | 30-Jun-17 | Purchase | 1,700,000 | $675,000.00 | $1,147,499,970,560.00 | 100% 1.7M to 3.4M |
